Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lymph nodes are small, bean-shaped organs that are part of the lymphatic system, playing a crucial role in the body's immune response. Sentinel lymph node mapping identifies the first lymph node(s) to which cancer cells are most likely to spread from a primary tumor. This process underpins sentinel lymph node biopsy (SLNB), where these specific nodes are identified, removed, and examined for metastatic cancer cells. Lymph nodes act as filters and serve as early sites for metastasis. Detection methods include blue dye injection and radiotracer injection, often combined for higher accuracy. Sentinel lymph node biopsy is less invasive than full nodal dissection, offering fewer complications.
N/A - Target is an anatomical structure, not a molecule
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lymph Node (Sentinel) (N/A).